Medical Research Stories
Read stories about initiatives in medical education taking place at Canada’s 17 Faculties of Medicine.
- Hydroxychloroquine shortages: when the enthusiasm for a potential cure affects patientsAmid initial public and scientific optimism for hydroxychloroquine (HCQ) as a potential treatment for COVID-19, health care professionals raised concerns about shortages of this inexpensive drug, which is widely used in the treatment of several rheumatic diseases such as arthritis. A new national survey of rheumatologists led by researchers at the McGill University Health Centre (MUHC) shows that most of them reported difficulties accessing or renewing the drug.
- Genome sequencing key to tracking, combatting COVID-19 virus: U of A researchersUniversity of Alberta researchers are leading a project to sequence virus genomes from COVID-19 patients in Alberta, in hopes of learning more about how the deadly virus spreads and how it can be stopped.
- Newly launched SeroTracker will monitor global antibody testing effortsAs the acute phase of the COVID-19 pandemic passes its peak, clinicians, public health officials, and policymakers around the world have a growing need to understand antibody patterns and potential immunity. To better inform their decision-making efforts, Canada’s COVID-19 Immunity Task Force recently supported the development of SeroTracker, a web platform that synthesizes findings from serological (antibody) testing efforts worldwide. [available in English only]
- Study explores online misinformation around immune boosting and COVID-19Anyone who spends time surfing the net knows it is commonplace to see online advertisements making dubious health claims. Now, with the arrival of COVID-19, misinformation related to the pandemic has proliferated.
- Canadian Scientists Develop Platform to Track Changes in Genetic Structure of COVID-19 VirusResearchers from the University of Toronto and University Health Network have designed an innovative tool for quickly tracking changes in the genetic structure of SARS-CoV-2, the virus that causes COVID-19.
- Pregnancy and birth in the time of a pandemic
When it comes to COVID-19 and pregnancy, there’s a lot we don’t know. UBC’s Dr. Deborah Money, professor in the faculty of medicine’s department of obstetrics and gynecology, is trying to fill that knowledge gap. She is leading a national surveillance study examining maternal and infant outcomes among pregnant women with COVID-19.
[available in English only]
- La quantité d’anticorps capables de neutraliser le virus diminue après six semainesSi les anticorps neutralisants sont à la base de la mise au point de futurs vaccins contre le SRAS-CoV-2, il faut néanmoins rester prudent, affirment des chercheurs et chercheuses du Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM). [available in French only]
- La perte de l’odorat et du goût associée scientifiquement à la COVID-19
Une équipe de recherche de l’Université de Sherbrooke et du CIUSSS de l’Estrie – CHUS, dirigée par le Pr Alex Carignan, a observé qu’environ 2/3 des usagers atteints du nouveau coronavirus SARS-CoV-2 présentaient comme symptômes une perte d’odorat et/ou de goût, de manière partielle ou complète. [available in French only]
- Virologist leads attempt to develop coronavirus nasal spray vaccine
A team of nine labs, led by uOttawa virologist Dr. Marc- André Langlois, has secured $1-million in CIHR funding to pursue a combination of tools against COVID-19, including therapeutic and diagnostic antibodies and a nasal spray vaccine.
- Speed dating begins between COVID-19 and drug hopefuls
In the fight against COVID-19, we may be sitting on the right weapons and not even know it. That’s the hope of a uOttawa-led three-lab team that just received rapid-response research funding from the Government of Canada.